의료용 폴리머 시장 예측(-2031년) : 유형, 용도, 제조 기술, 지역별

The medical polymer market is projected to reach USD 71.92 billion by 2031 from USD 48.27 billion in 2026, at a CAGR of 8.3% during the forecast period. The medical polymer market is experiencing rapid growth due to progress in healthcare, materials engineering, and patient-focused innovation. The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating a preference for advanced polymers that provide flexibility, security, and accuracy.

The considerable shift in the use of disposable medical products for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes or be bioresorbable, offering opportunities in the areas of drug delivery devices and tissue engineering. The proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There is increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers.

"The medical elastomers segment is estimated to account for the second-largest share of the medical polymer market during the forecast period."

Medical elastomers account for the second-largest share of the medical polymer market due to their flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications in critical healthcare. Many of the devoted elastomer applications are products used to contain a fluid or products that need to be manipulated with constant movement, stretching or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in the literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance in elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective product production at considerably large amounts.

"Medical disposables accounted for the second-largest application in the medical polymer market during the forecast period."

Medical disposables are the second-largest application in the medical polymer market. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and to maintain a sterile environment. The emphasis on infection prevention and the regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in developing areas, is driving demand for good quality disposables. The convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As health care continues to focus on safety, cost-effective practices and efficiencies, polymer medical disposables will be an important future growth area.

"Injection molding is the second-largest manufacturing technology in the medical polymer market during the forecast period."

Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, such as housing for diagnostic equipment, surgical instrument handles, syringes, connectors, and components of implantable devices. Injection molding is compatible with many medical-grade polymers, such as polycarbonate, polypropylene, and ABS. Injection molding can be made to tight tolerances with complex geometries, all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce item at large volumes while being cost-effective with high-quality output. Recent advancements in multi-shot and micro fabrications further enhance application range as well.

"North America market is projected to be the second-fastest growing region in the medical polymer market during the forecast period."

North America is the second-fastest growing region in the medical polymer market. Per capita healthcare expenses are rising, driven by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other world region as healthcare advances. The US has one of the most innovative healthcare environments in the world. The country has a developed healthcare infrastructure, a strong research and development (R&D) ecosystem, and a strong partnership with the polymer industry.

Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments, and information was gathered through secondary research.

The breakdown of primary interviews is given below:

• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
• By Designation: Directors: 30%, Managers: 20%, and Others: 50%
• By Region: Asia Pacific: 40%, Europe: 10%, North America: 20%, Middle East & Africa: 20%, and South America: 10%

BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US) are some of the key players in the medical polymer market.

The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical polymer market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), challenges (Cost constraints for novel materials, Long-term durability and degradation control).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical polymer market
• Market Development: Comprehensive information about lucrative markets - the report analyses the medical polymer market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 UNITS CONSIDERED
• 1.7 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET
• 3.2 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE AND COUNTRY
• 3.3 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
• 3.4 MEDICAL POLYMER MARKET, BY APPLICATION
• 3.5 MEDICAL POLYMER MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Increasing demand for biocompatible and high-performance materials
    • 4.2.1.2 Growing aging population and healthcare expenditure
    • 4.2.1.3 Advancements in medical devices and minimally invasive procedures
    • 4.2.1.4 Rise in chronic diseases
    • 4.2.1.5 Increasing adoption of stringent medical-grade material and biocompatibility requirements
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Stringent regulatory and material qualification requirements
    • 4.2.2.2 High competition from alternative polymers and materials
    • 4.2.2.3 Environmental sustainability and chemical regulatory concerns
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growth in regenerative medicine and tissue engineering
    • 4.2.3.2 Advancements in biodegradable and bioresorbable polymers
    • 4.2.3.3 Growing adoption of 3D-printed and patient-specific medical devices
    • 4.2.3.4 Increasing demand for minimally invasive and patient-specific devices
  • 4.2.4 CHALLENGES
    • 4.2.4.1 High cost and lengthy qualification of novel medical-grade materials
    • 4.2.4.2 Balancing sustainability with durability, sterilization, and biocompatibility
    • 4.2.4.3 Evolving restrictions on PFAS and other chemicals used in medical polymer applications
• 4.3 UNMET NEEDS IN MEDICAL POLYMER MARKET
  • 4.3.1 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
  • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT FROM NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 GLOBAL GDP TRENDS
  • 5.2.2 HEALTHCARE INDUSTRY TRENDS
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RAW MATERIAL SUPPLIERS
  • 5.3.2 MANUFACTURERS
  • 5.3.3 DISTRIBUTION
  • 5.3.4 END USERS
• 5.4 ECOSYSTEM
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5.2 AVERAGE SELLING PRICE TREND, BY APPLICATION
• 5.6 TRADE ANALYSIS
  • 5.6.1 IMPORT SCENARIO
  • 5.6.2 EXPORT SCENARIO
• 5.7 KEY CONFERENCES & EVENTS
• 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
  • 5.10.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
• 5.11 IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET
  • 5.11.1 INTRODUCTION
  • 5.11.2 KEY TARIFF RATES
  • 5.11.3 PRICE IMPACT ANALYSIS
  • 5.11.4 IMPACT ON KEY COUNTRIES/REGIONS
    • 5.11.4.1 North America
    • 5.11.4.2 Europe
    • 5.11.4.3 Asia Pacific
  • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY TECHNOLOGIES
    • 6.1.1.1 Biocompatible and medical-grade polymers
    • 6.1.1.2 Medical-grade thermoplastic elastomers
    • 6.1.1.3 High-performance medical polymer engineering
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 Polymer-based additive manufacturing
    • 6.1.2.2 Medical polymer surface modification techniques
    • 6.1.2.3 Advanced polymer compounding and processing
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.2.1 SHORT TERM (2025-2027) | MEDICAL-GRADE MATERIAL INNOVATION & PERFORMANCE OPTIMIZATION
  • 6.2.2 MID-TERM (2027-2030) | ADVANCED MATERIALS, SMART MANUFACTURING & APPLICATION INTEGRATION
  • 6.2.3 LONG TERM (2030-2035+) | SUSTAINABLE HIGH-PERFORMANCE POLYMERS & INTELLIGENT MANUFACTURING
• 6.3 PATENT ANALYSIS
  • 6.3.1 LEGAL STATUS OF PATENTS
  • 6.3.2 JURISDICTION ANALYSIS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 HIGH-PERFORMANCE POLYMERS FOR MEDICAL INSTRUMENTS & DEVICES
  • 6.4.2 SUSTAINABLE, BIORESORBABLE & BIO-BASED MEDICAL POLYMERS
  • 6.4.3 ADDITIVE MANUFACTURING & PATIENT-SPECIFIC MEDICAL POLYMERS
  • 6.4.4 ADVANCED POLYMER PROCESSING, SURFACE ENGINEERING & SMART MATERIALS
• 6.5 IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET
  • 6.5.1 TOP USE CASES AND MARKET POTENTIAL OF MEDICAL POLYMERS
  • 6.5.2 BEST PRACTICES IN MEDICAL POLYMER PROCESSING
  • 6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL POLYMER MARKET
  • 6.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 6.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL POLYMER MARKET

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES
• 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYING BEHAVIOUR

• 8.1 INTRODUCTION
• 8.2 DECISION-MAKING PROCESS
• 8.3 KEY STAKEHOLDERS & BUYING CRITERIA
  • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.3.2 BUYING CRITERIA
• 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 8.6 MARKET PROFITABILITY
  • 8.6.1 REVENUE POTENTIAL
  • 8.6.2 COST DYNAMICS
  • 8.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES

9 MEDICAL POLYMER MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 MEDICAL DISPOSABLES
  • 9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
  • 9.2.2 GLOVES
  • 9.2.3 SYRINGES
  • 9.2.4 MEDICAL BAGS
  • 9.2.5 OTHER MEDICAL DISPOSABLES
• 9.3 MEDICAL INSTRUMENTS & DEVICES
  • 9.3.1 INCREASING USE OF ADVANCED AND MINIMALLY INVASIVE MEDICAL DEVICES TO DRIVE MARKET
  • 9.3.2 MEDICAL TUBES
  • 9.3.3 CATHETERS
  • 9.3.4 DRUG DELIVERY INSTRUMENTS
  • 9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES
• 9.4 PROSTHETICS
  • 9.4.1 RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET
  • 9.4.2 IMPLANTS
  • 9.4.3 LIMB PROSTHESIS
  • 9.4.4 OTHER PROSTHETICS APPLICATIONS
• 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS
  • 9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
  • 9.5.2 DENTAL TOOLS
  • 9.5.3 SURGICAL INSTRUMENTS
  • 9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
• 9.6 OTHER APPLICATIONS

10 MEDICAL POLYMER MARKET, BY TYPE

• 10.1 INTRODUCTION
• 10.2 MEDICAL PLASTICS
  • 10.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
  • 10.2.2 POLYPROPYLENE
  • 10.2.3 POLYVINYL CHLORIDE
  • 10.2.4 POLYETHYLENE
  • 10.2.5 POLYSTYRENE
  • 10.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS
    • 10.2.6.1 Polyether ether ketone
    • 10.2.6.2 Nylon/polyamide
    • 10.2.6.3 Polyphenylsulfone
    • 10.2.6.4 Polysulfones
    • 10.2.6.5 Polymethyl methacrylate
    • 10.2.6.6 Polycarbonate
    • 10.2.6.7 Acrylonitrile butadiene styrene
    • 10.2.6.8 Other engineering & high-performance plastics
  • 10.2.7 OTHER MEDICAL PLASTICS
• 10.3 MEDICAL ELASTOMERS
  • 10.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
  • 10.3.2 SILICONE
  • 10.3.3 THERMOPLASTIC ELASTOMERS
    • 10.3.3.1 Thermoplastic polyurethane
    • 10.3.3.2 Thermoplastic vulcanizates
    • 10.3.3.3 Thermoplastic styrenic elastomers
      • 10.3.3.3.1 Poly (styrene-butadiene-styrene)
      • 10.3.3.3.2 Styrene-ethylene-butylene-styrene
    • 10.3.3.4 Thermoplastic copolyester elastomers
  • 10.3.4 OTHER MEDICAL ELASTOMERS

11 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY

• 11.1 INTRODUCTION
• 11.2 EXTRUSION TUBING
  • 11.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
• 11.3 COMPRESSION MOLDING
  • 11.3.1 RISING USE IN PROSTHETIC AND ORTHOPEDIC COMPONENTS TO FUEL DEMAND
• 11.4 INJECTION MOLDING
  • 11.4.1 INCREASING USE IN SYRINGES, SURGICAL INSTRUMENTS, AND MEDICAL DEVICE COMPONENTS TO SUPPORT MARKET GROWTH
• 11.5 OTHER MANUFACTURING TECHNOLOGIES

12 MEDICAL POLYMER MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Strong medical R&D and device innovation to support demand
  • 12.2.2 CANADA
    • 12.2.2.1 Expanding medical device manufacturing and healthcare demand to support market
  • 12.2.3 MEXICO
    • 12.2.3.1 Expansion of medical-device manufacturing to support market growth
• 12.3 ASIA PACIFIC
  • 12.3.1 CHINA
    • 12.3.1.1 Establishment of medical device manufacturing units and investment in healthcare-related sectors to drive market
  • 12.3.2 INDIA
    • 12.3.2.1 Expansion of domestic medical device manufacturing to drive demand
  • 12.3.3 SOUTH KOREA
    • 12.3.3.1 Advanced medical device manufacturing and technology development to drive market
  • 12.3.4 JAPAN
    • 12.3.4.1 Aging population and advanced medical-device technologies to support market growth
  • 12.3.5 AUSTRALIA
    • 12.3.5.1 Strong medical device manufacturing and regulatory standards to support market growth
  • 12.3.6 REST OF ASIA PACIFIC
• 12.4 EUROPE
  • 12.4.1 GERMANY
    • 12.4.1.1 Advanced medical device manufacturing and aging population to support market growth
  • 12.4.2 FRANCE
    • 12.4.2.1 Aging population and advanced medical-device manufacturing to support market growth
  • 12.4.3 UK
    • 12.4.3.1 Growing medical device industry and government support for innovation to drive market
  • 12.4.4 ITALY
    • 12.4.4.1 Strong production facilities with presence of global players to propel market growth
  • 12.4.5 SPAIN
    • 12.4.5.1 Growing medical technology industry and government support to drive market
  • 12.4.6 REST OF EUROPE
• 12.5 SOUTH AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Aging population and expanding medical device industry to drive market
  • 12.5.2 ARGENTINA
    • 12.5.2.1 High import dependence and evolving medical device regulations to support market
  • 12.5.3 REST OF SOUTH AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 GCC COUNTRIES
    • 12.6.1.1 Saudi Arabia
      • 12.6.1.1.1 Healthcare transformation and medical device localization to support market growth
    • 12.6.1.2 UAE
      • 12.6.1.2.1 Modernization of healthcare industry to drive market
    • 12.6.1.3 Rest of GCC
  • 12.6.2 SOUTH AFRICA
    • 12.6.2.1 Localization of medical device production to support market
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYERS' STRATEGIES
• 13.3 REVENUE ANALYSIS, 2022-2025
• 13.4 MARKET SHARE ANALYSIS, 2025
• 13.5 COMPANY VALUATION AND FINANCIAL METRICS
• 13.6 BRAND/PRODUCT COMPARISON ANALYSIS
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
  • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.7.5.1 Company footprint
    • 13.7.5.2 Region footprint
    • 13.7.5.3 Type footprint
    • 13.7.5.4 Manufacturing technology footprint
    • 13.7.5.5 Application footprint
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
    • 13.8.5.1 Detailed list of key startups/SMEs
    • 13.8.5.2 Competitive benchmarking of key startups/SMEs
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 MAJOR PLAYERS
  • 14.1.1 BASF SE
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Services/Solutions offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches
      • 14.1.1.3.2 Expansions
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 SABIC
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Services/Solutions offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches
      • 14.1.2.3.2 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 COVESTRO AG
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Services/Solutions offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches
      • 14.1.3.3.2 Expansions
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Key strengths
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 CELANESE CORPORATION
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Services/Solutions offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Deals
      • 14.1.4.3.2 Expansions
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key strengths
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 EVONIK INDUSTRIES
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Services/Solutions offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product launches
      • 14.1.5.3.2 Deals
      • 14.1.5.3.3 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 ARKEMA
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Services/Solutions offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
      • 14.1.6.3.2 Expansions
    • 14.1.6.4 MnM view
  • 14.1.7 SOLVAY
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Services/Solutions offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches
    • 14.1.7.4 MnM view
  • 14.1.8 KURARAY CO., LTD.
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Services/Solutions offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Expansions
    • 14.1.8.4 MnM view
  • 14.1.9 MOMENTIVE PERFORMANCE MATERIALS INC.
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Services/Solutions offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Product launches
      • 14.1.9.3.2 Expansions
    • 14.1.9.4 MnM view
  • 14.1.10 DUPONT
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Services/Solutions offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches
      • 14.1.10.3.2 Deals
      • 14.1.10.3.3 Expansions
    • 14.1.10.4 MnM view
• 14.2 OTHER PLAYERS
  • 14.2.1 TRINSEO
  • 14.2.2 KRATON CORPORATION
  • 14.2.3 TOTAL PLASTICS
  • 14.2.4 SIMONA AMERICA
  • 14.2.5 DSM
  • 14.2.6 INVIBIO
  • 14.2.7 AVIENT CORPORATION
  • 14.2.8 RTP COMPANY
  • 14.2.9 TEKNI-PLEX, INC.
  • 14.2.10 TEKNOR APEX
  • 14.2.11 MITSUBISHI CHEMICAL ADVANCED MATERIALS
  • 14.2.12 WACKER CHEMIE
  • 14.2.13 HARDIE POLYMERS
  • 14.2.14 ELIX POLYMERS
  • 14.2.15 INNOVATIVE POLYMER COMPOUNDS LTD.

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 List of major secondary sources
    • 15.1.1.2 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 List of primary interview participants-demand and supply side
    • 15.1.2.3 Key industry insights
    • 15.1.2.4 Breakdown of primary interviews
• 15.2 MARKET SIZE ESTIMATION
  • 15.2.1 BOTTOM-UP APPROACH
  • 15.2.2 TOP-DOWN APPROACH
• 15.3 BASE NUMBER CALCULATION
  • 15.3.1 DEMAND-SIDE APPROACH
  • 15.3.2 SUPPLY-SIDE APPROACH
• 15.4 MARKET FORECAST APPROACH
  • 15.4.1 SUPPLY SIDE
  • 15.4.2 DEMAND SIDE
• 15.5 DATA TRIANGULATION
• 15.6 FACTOR ANALYSIS
• 15.7 ASSUMPTIONS
• 15.8 LIMITATIONS AND RISKS

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS